Literature DB >> 21812868

Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state.

Minoru Narita1, Satoshi Imai, Atsushi Nakamura, Ayumi Ozeki, Megumi Asato, Mahardian Rahmadi, Yuka Sudo, Minoru Hojo, Yasuhito Uezono, Lakshmi A Devi, Naoko Kuzumaki, Tsutomu Suzuki.   

Abstract

In the present study, we investigated the possible development of tolerance to the antihyperalgesic effect of µ-opioid receptor (MOR) agonists under a neuropathic pain-like state. Repeated treatment with fentanyl, but not morphine or oxycodone, produced a rapid development of tolerance to its antihyperalgesic effect in mice with sciatic nerve ligation. Like the behavioral study, G-protein activation induced by fentanyl was significantly reduced in membranes obtained from the spinal cord of nerve-ligated mice with in vivo repeated injection of fentanyl. In β-endorphin-knockout mice with nerve ligation, developed tolerance to the antihyperalgesic effect of fentanyl was abolished, and reduced G-protein activation by fentanyl after nerve ligation with fentanyl was reversed to the normal level. The present findings indicate that released β-endorphin within the spinal cord may be implicated in the rapid development of tolerance to fentanyl under a neuropathic pain-like state.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812868      PMCID: PMC3852690          DOI: 10.1111/j.1369-1600.2011.00354.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  22 in total

Review 1.  Opioid tolerance-in search of the holy grail.

Authors:  Brigitte L Kieffer; Christopher J Evans
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

Review 2.  Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins.

Authors:  Audrey Claing; Stéphane A Laporte; Marc G Caron; Robert J Lefkowitz
Journal:  Prog Neurobiol       Date:  2002-02       Impact factor: 11.685

Review 3.  Desensitization of G protein-coupled receptors and neuronal functions.

Authors:  Raul R Gainetdinov; Richard T Premont; Laura M Bohn; Robert J Lefkowitz; Marc G Caron
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

4.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

5.  Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

Authors:  J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

6.  Functional coupling, desensitization and internalization of virally expressed mu opioid receptors in cultured dorsal root ganglion neurons from mu opioid receptor knockout mice.

Authors:  W M Walwyn; D E Keith; W Wei; A M Tan; C W Xie; C J Evans; B L Kieffer; N T Maidment
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state.

Authors:  Keiichi Niikura; Minoru Narita; Michiko Narita; Atsushi Nakamura; Daiki Okutsu; Ayumi Ozeki; Kana Kurahashi; Yasuhisa Kobayashi; Masami Suzuki; Tsutomu Suzuki
Journal:  Neurosci Lett       Date:  2008-03-04       Impact factor: 3.046

8.  Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375.

Authors:  Stefan Schulz; Dana Mayer; Manuela Pfeiffer; Ralf Stumm; Thomas Koch; Volker Höllt
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

9.  Organizing pain control and rehabilitation service in a cancer centre.

Authors:  V Ventafridda; F De Conno
Journal:  Int Rehabil Med       Date:  1981

10.  Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons.

Authors:  J G Minnis; S Patierno; S E Kohlmeier; N C Brecha; M Tonini; C Sternini
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  11 in total

Review 1.  Endogenous opioid peptides in the descending pain modulatory circuit.

Authors:  Elena E Bagley; Susan L Ingram
Journal:  Neuropharmacology       Date:  2020-05-15       Impact factor: 5.250

Review 2.  Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.

Authors:  Rafael Maldonado; Josep Eladi Baños; David Cabañero
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

Review 3.  Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment.

Authors:  Sandra D Comer; Catherine M Cahill
Journal:  Neurosci Biobehav Rev       Date:  2018-12-05       Impact factor: 8.989

4.  Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning.

Authors:  Andrew J Kassick; Mariah Wu; Diego Luengas; Mohammad Ebqa'ai; L P Tharika Nirmani; Nestor Tomycz; Toby L Nelson; Marco Pravetoni; Michael D Raleigh; Saadyah Averick
Journal:  ACS Pharmacol Transl Sci       Date:  2021-08-26

5.  Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.

Authors:  Michael D Leitl; S Stevens Negus
Journal:  Behav Pharmacol       Date:  2016-06       Impact factor: 2.293

6.  Dopamine D₄ receptor counteracts morphine-induced changes in µ opioid receptor signaling in the striosomes of the rat caudate putamen.

Authors:  Diana Suárez-Boomgaard; Belén Gago; Alejandra Valderrama-Carvajal; Ruth Roales-Buján; Kathleen Van Craenenbroeck; Jolien Duchou; Dasiel O Borroto-Escuela; José Medina-Luque; Adelaida de la Calle; Kjell Fuxe; Alicia Rivera
Journal:  Int J Mol Sci       Date:  2014-01-21       Impact factor: 5.923

7.  Gabapentin enhances the morphine anti-nociceptive effect in neuropathic pain via the interleukin-10-heme oxygenase-1 signalling pathway in rats.

Authors:  Yu-Hua Bao; Quan-Hong Zhou; Rui Chen; Hao Xu; Lu-Lu Zeng; Xin Zhang; Wei Jiang; Dong-Ping Du
Journal:  J Mol Neurosci       Date:  2014-02-27       Impact factor: 3.444

8.  Intrathecal Dexmedetomidine and Fentanyl as Adjuvant to Bupivacaine on Duration of Spinal Block in Addicted Patients.

Authors:  Farhad Safari; Reza Aminnejad; Seyed Amir Mohajerani; Farshad Farivar; Kamran Mottaghi; Hasan Safdari
Journal:  Anesth Pain Med       Date:  2016-01-31

9.  Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist.

Authors:  Seira Doi; Tomohisa Mori; Naoki Uzawa; Takamichi Arima; Tomoyuki Takahashi; Masashi Uchida; Ayaka Yawata; Michiko Narita; Yasuhito Uezono; Tsutomu Suzuki; Minoru Narita
Journal:  Mol Pain       Date:  2016-06-17       Impact factor: 3.395

10.  Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.

Authors:  Tomohisa Mori; Naoko Kuzumaki; Takamichi Arima; Michiko Narita; Ryunosuke Tateishi; Takashige Kondo; Yusuke Hamada; Hirotsugu Kuwata; Miho Kawata; Mitsuaki Yamazaki; Kazuyuki Sugita; Akinobu Matsuzawa; Kanae Baba; Takayasu Yamauchi; Kimio Higashiyama; Miki Nonaka; Kanako Miyano; Yasuhito Uezono; Minoru Narita
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.